Company / Net Income
AbCellera Biologics Inc. Net Income History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$146.4M
FY2025
5-year range
-$162.9M / $118.9M
FY2021-FY2025
Trend
+10.1%
vs FY2024
Sector context
#129 of 216
Health Care
What the data says
At -$146M, AbCellera Biologics Inc.'s net income ranks #129 of 216 in the Health Care sector. Net Income returned to growth in FY2025 after 2 years of decline, reaching -$146M.
Based on SEC 10-K filings.
-$146M in FY2025.
Remained stable around -$146M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#129 of 216 in Health CareTop 60% of 216This company -$146.4M Sector average $454.1M
▼
-132.2% below sector average
Key checks
Key Insights
- In FY2025, net income increased 10.1% year-over-year.
- Ranks #129 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2022.
- Lowest net income in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$146.4M | +10.1% |
| FY2024 | -$162.9M | -11.2% |
| FY2023 | -$146.4M | -223.1% |
| FY2022 | $118.9M | +5478.5% |
| FY2021 | -$2.2M | -101.9% |
| FY2020 | $118.9M | +5478.5% |
| FY2019 | -$2.2M | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026